C22orf9 is a protein that is encoded by the C22orf9 gene, situated on the 22nd chromosome in humans. The specific functions and roles of C22orf9 remain largely undefined, and as such, it is designated as an open reading frame (orf), indicating that it is a segment of DNA that has been identified to potentially code for a protein but whose function is not yet clear.The research on proteins like C22orf9 typically involves a combination of bioinformatics approaches to predict protein structure and function, and experimental verification to confirm these predictions and to identify the protein's role in the cell. Such studies might explore the protein's expression patterns across different tissues and developmental stages, its subcellular localization, and its interactions with other proteins.The study of C22orf9 may reveal its participation in specific cellular pathways or processes, such as signal transduction, gene regulation, or metabolic pathways. It is also possible that C22orf9 could be implicated in disease processes if mutations or alterations in its expression are discovered to be associated with particular pathologies.
SEE ALSO...
Items 11 to 12 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Bafilomycin A1 | 88899-55-2 | sc-201550 sc-201550A sc-201550B sc-201550C | 100 µg 1 mg 5 mg 10 mg | $98.00 $255.00 $765.00 $1457.00 | 280 | |
Bafilomycin A1 inhibits lysosomal function, which could impact cellular pathways involving KIAA0930. | ||||||
Cyclosporin A | 59865-13-3 | sc-3503 sc-3503-CW sc-3503A sc-3503B sc-3503C sc-3503D | 100 mg 100 mg 500 mg 10 g 25 g 100 g | $63.00 $92.00 $250.00 $485.00 $1035.00 $2141.00 | 69 | |
Cyclosporine A inhibits calcineurin, affecting signal transduction pathways that could influence KIAA0930. | ||||||